Expression of Apoptosis-Related Antigen on Eosinophils in Chronic Eosinophilic Pneumonia

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 64-66

  Saita, Naoki ^a   Yamanaka, Tohru ^a   Kohrogi, Hirotsugu ^a   Matsumoto, Mitsuhiro ^a   Suga, Moritaka ^a   Ando, Masayuki ^a   Hirashima, Mitsuomi ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Bcl 2; Eosinophil chemotactic factor; Eosinophil heterogeneity; Eosinophilic pneumonia; Fas

Indexed keywords

EOSINOPHIL CHEMOTACTIC FACTOR; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; PROTEIN BCL 2;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; BLOOD; CASE REPORT; CELL SUBPOPULATION; CHEMOTAXIS; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; LOEFFLER PNEUMONIA; LUNG LAVAGE; LYMPHOID CELL LINE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD95; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS, LEUKOCYTE; CHRONIC DISEASE; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY EOSINOPHILIA;

EID: 0030719873     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237721     Document Type: Article

References (11)

1. Hirashima M, Ueno M, Higuchi S, Matsumoto T, Sakata K, Matsumoto R, Adachi M: Establishment of human T-ccll line constitutively producing several eosinophil chemotactic lym-phokines and their functional heterogeneity on eosinophils. Lymphokine Cytokine 1992; 11: 331-338.
2. Saita N, Hirayama S, Sugimoto M, Ando M, Hirashima M: Chemotactic heterogeneity of eosinophils in idiopathic pulmonary eosino-philia. Int Arch Allergy Appl Immunol 1995; 108:25-27.
3. Saita N, Ucno M, Yoshida M, Kimura T, Ando M, Hirashima M: Chemotactic heterogeneity of eosinophils in Kimura’s disease. Int Arch Allergy Appl Immunol 1994;104:21-23.
4. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sei 1992;83:639-648.
5. Trauth BC, Klas C, Peters AM: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-303.
6. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627.
7. Carrington CB, Addington WW, Goff AM, Madoff IM, Marks A, Schwaber JR, Gacnslcr EA: Chronic eosinophilic pneumonia. N Engl J Med 1969;280:787-798.
8. Saita N, Yamanaka T, Sugimoto M, Kohrogi H, Suga M, Ando M, Hirashima M: Heterogeneity of eosinophils in chronic eosinophilic pneumonia. Int Arch Allergy Appl Immunol 1996;111:28-30.
9. Nishikawa K, Morii T, Ako H, Hamada K, Sai-to S, Narita N: In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosin-oph:ls. J Allergy Clin Immunol 1992;90:169-174.
10. Whyte MKB, Hardwick SJ, Meagher L, Savill J, Haslett C: Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. J Clin Invest 1993;92: 446-455.
11. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH. Woolley MJ: Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154:237-243.